These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Beneficial effects of thromboxane receptor antagonists in acute cardiovascular crises. Lefer AM Prog Clin Biol Res; 1987; 242():221-8. PubMed ID: 2959963 [No Abstract] [Full Text] [Related]
23. Capillary gas chromatographic method for the determination of the thromboxane A2 receptor antagonist S-1452 and its metabolites in human urine. Okamoto J; Hirai E; Suzuki Y; Fujimoto K; Kitagawa T; Matsubara T J Chromatogr; 1992 Nov; 583(1):53-62. PubMed ID: 1484092 [TBL] [Abstract][Full Text] [Related]
24. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. Swann PG; Venton DL; Le Breton GC FEBS Lett; 1989 Jan; 243(2):244-6. PubMed ID: 2537230 [TBL] [Abstract][Full Text] [Related]
25. ICI 180080, a novel selective thromboxane receptor antagonist: synthesis and relative activity. Brown GR; Foubister AJ J Pharm Pharmacol; 1986 Sep; 38(9):706-8. PubMed ID: 2877076 [TBL] [Abstract][Full Text] [Related]
34. Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177). Schrör K; Thiemermann C Br J Pharmacol; 1986 Apr; 87(4):631-7. PubMed ID: 3011166 [TBL] [Abstract][Full Text] [Related]
35. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe. Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474 [TBL] [Abstract][Full Text] [Related]
36. AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. Brittain RT; Boutal L; Carter MC; Coleman RA; Collington EW; Geisow HP; Hallett P; Hornby EJ; Humphrey PP; Jack D Circulation; 1985 Dec; 72(6):1208-18. PubMed ID: 2998642 [TBL] [Abstract][Full Text] [Related]